Tower Research Capital LLC (TRC) - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 109 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$0250.0%0.00%
Q4 2022$0
-100.0%
25
-99.8%
0.00%
Q3 2022$7,000
-46.2%
16,548
+10.3%
0.00%
Q2 2022$13,000
+225.0%
15,002
+1908.3%
0.00%
Q1 2022$4,000
-95.7%
747
-92.1%
0.00%
-100.0%
Q4 2021$92,000
-45.9%
9,417
-0.9%
0.00%
-50.0%
Q3 2021$170,000
+95.4%
9,505
+167.2%
0.00%
+100.0%
Q2 2021$87,0000.0%3,557
+7.7%
0.00%
+100.0%
Q1 2021$87,000
+200.0%
3,302
-14.1%
0.00%0.0%
Q4 2020$29,000
-83.1%
3,843
-88.8%
0.00%
-50.0%
Q3 2020$172,000
+196.6%
34,340
+255.4%
0.00%0.0%
Q2 2020$58,000
+1833.3%
9,663
+1543.4%
0.00%
Q1 2020$3,000
-95.3%
588
-91.3%
0.00%
-100.0%
Q4 2019$64,000
+814.3%
6,722
+650.2%
0.01%
Q3 2019$7,000
-89.6%
896
-79.1%
0.00%
-100.0%
Q2 2019$67,000
+204.5%
4,278
+210.7%
0.01%
+150.0%
Q4 2018$22,0001,3770.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,296,526$290,671,0005.29%
HARBOURVEST PARTNERS LLC 986,878$7,490,0002.93%
Abbot Financial Management, Inc. 537,000$4,076,0002.35%
Artal Group S.A. 3,778,913$28,682,0000.62%
HITE Hedge Asset Management LLC 88,740$674,0000.16%
Virtus ETF Advisers LLC 33,793$256,0000.11%
JACOBS LEVY EQUITY MANAGEMENT, INC 394,909$2,997,0000.03%
Baillie Gifford 4,710,061$35,749,0000.02%
Caption Management, LLC 86,000$652,0000.02%
Blueshift Asset Management, LLC 14,626$111,0000.01%
View complete list of RUBIUS THERAPEUTICS INC shareholders